Folixia Tablet
NDC Package 85477-902-30
Package Information
Folixia (multivitamin) tablets is a medication a multivitamin product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. This formulation utilizes a tablet delivery system. Marketed by Oncora Pharma, Llc, this product is identified by NDC 85477-902.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 4.5 mg/1
- ASCORBIC ACID 60 mg/1
- BETA CAROTENE .3 mg/1
- BIOTIN .28 mg/1
- CALCIUM CARBONATE 80 mg/1
- CHOLECALCIFEROL .1 mg/1
- CYANOCOBALAMIN .013 mg/1
- FERROUS BISGLYCINATE 20 mg/1
- FOLIC ACID 1.67 mg/1
- MAGNESIUM OXIDE 25 mg/1
- POTASSIUM IODIDE .15 mg/1
- PYRIDOXINE HYDROCHLORIDE 26 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 85477 - Oncora Pharma, Llc
- 85477-902 - Folixia
- 85477-902-30 - 30 TABLET in 1 BOTTLE
- 85477-902 - Folixia
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85477-902-30 identifies a specific commercial package of 30 tablet in 1 bottle of Folixia, a human prescription drug labeled by Oncora Pharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; beta carotene; biotin; calcium carbonate; cholecalciferol; cyanocobalamin; ferrous bisglycinate; folic acid; magnesium oxide; potassium iodide; pyridoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Oncora Pharma, Llc on February 24, 2025. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is a multivitamin product used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health.
How is this Oncora Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85477090230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.